Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1AstraZeneca Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AstraZeneca Canada Inc.

arrow
Pharmaconex
Not Confirmed

AstraZeneca Canada Inc.

Country
arrow
Pharmaconex
Not Confirmed

Tremelimumab

Brand Name : IMJUDO

Patent Number : 2600434

Filing Date : 2006-03-02

Strength per Unit : 20 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2026-03-02

Date Granted : 2017-09-19

blank